Promoted by professionals, Cardkem  started operations in 1993 and currently is a Rs 250 million ( US $ 6.25 million ) turnover group…. with business interests in manufacturing API intermediates, bromine compounds, other fine chemicals as well as in contract manufacturing…. in dedicated and m xultipurpose facilities having about 25000 ltrs of  glass lined reactor  capacity and 75000 ltrs of SS reactor capacity, installed and under installation….. with an ambitious target to doubling the turnover to over  Rs 500 million in 3 years.
   
  An upcoming RND
centre and pilot plant …..
with approval from FDA…..
 
 
 
We Manufacture..
Bromine compounds
APIs' intermediates
Cephalosporin’s related APIs' intermediates
Intermediates - Contract manufacturing
Other compounds
A commitment thru personnel with exposure to the pharma industry……,
thru a system being upgraded
to meet ISO 9001:2000
…….
 
 
 
cardkem@narmada.net.in